Biocon

Market Cap: Large Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE376G01013
NSEID: BIOCON
BSEID: 532523

INR

317.90

12.7 (4.16%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 23.62 lacs

Click here to access the older version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Laurus Labs

Divi's Lab.

Cipla

Ipca Labs

Sun Pharma.Inds.

Torrent Pharma

Ajanta Pharma

Piramal Pharma

Syngene Intl.

Biocon

Mankind Pharma

Why is Biocon Ltd. ?

Poor long term growth as Operating profit has grown by an annual rate 2.41% of over the last 5 years

Negative results in Dec 24

PBT LESS OI(Q) At Rs 103.00 cr has Fallen at -20.7 %
PAT(Q) At Rs 15.68 cr has Fallen at -95.5 %

Stock is technically in a Bearish range

The technical trend has deteriorated from Mildly Bearish on 07-Apr-25 and has generated 3.07% returns since then
Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Biocon for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Biocon

14.15%

0.36

37.93%

SENSEX

0.45%

0.03

14.48%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

18.53%

EBIT Growth (5y)

2.41%

EBIT to Interest (avg)

8.20

Debt to EBITDA (avg)

3.60

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.54

Tax Ratio

30.60%

Dividend Payout Ratio

5.87%

Pledged Shares

Institutional Holding

21.02%

ROCE (avg)

9.22%

ROE (avg)

7.29%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.75

EV to EBIT

38.58

EV to EBITDA

17.07

EV to Capital Employed

1.45

EV to Sales

3.44

PEG Ratio

Dividend Yield

0.16%

ROCE (Latest)

4.28%

ROE (Latest)

6.64%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company

NO KEY POSITIVE TRIGGERS

-8What is not working for the Company

PBT LESS OI(Q)

At Rs 103.00 cr has Fallen at -20.7 %

PAT(Q)

At Rs 15.68 cr has Fallen at -95.5 %

Loading Valuation Snapshot...

Here's what is not working for Biocon

Profit Before Tax less Other Income (PBT) - Quarterly

At Rs 103.00 cr has Fallen at -20.7 %

over average PBT of the previous four quarters of Rs 129.90 Cr

MOJO Watch

Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly

At Rs 15.68 cr has Fallen at -95.5 %

over average PAT of the previous four quarters of Rs 348.59 Cr

MOJO Watch

Near term PAT trend is very negative

PAT (Rs Cr)